|
gptkbp:instanceOf
|
gptkb:drug
gonadotropin-releasing hormone antagonist
|
|
gptkbp:approvedBy
|
1999
|
|
gptkbp:ATCCode
|
H01CC02
|
|
gptkbp:brand
|
gptkb:Cetrotide
|
|
gptkbp:CASNumber
|
120287-85-6
|
|
gptkbp:contraindication
|
pregnancy
hypersensitivity to cetrorelix
|
|
gptkbp:developedBy
|
ASTA Medica
|
|
gptkbp:eliminationHalfLife
|
5-10 hours
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:form
|
powder for injection
|
|
gptkbp:hasMolecularFormula
|
C70H92ClN17O14
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
cetrorelix
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
inhibits gonadotropin secretion
|
|
gptkbp:metabolism
|
hepatic
|
|
gptkbp:molecularWeight
|
1431.04 g/mol
|
|
gptkbp:pregnancyCategory
|
D
X
X (contraindicated)
|
|
gptkbp:proteinBinding
|
86%
|
|
gptkbp:PubChem_CID
|
25074465
24579935
CHEMBL1201392
DB00050
|
|
gptkbp:routeOfAdministration
|
subcutaneous injection
|
|
gptkbp:sideEffect
|
nausea
abdominal pain
headache
|
|
gptkbp:synonym
|
D-Ser(tBu)6,des-Gly10,Pro9-NH2-LHRH
|
|
gptkbp:UNII
|
QY7S53918D
|
|
gptkbp:usedFor
|
in vitro fertilization
assisted reproductive technology
|
|
gptkbp:bfsParent
|
gptkb:Cetrotide
|
|
gptkbp:bfsLayer
|
6
|